CDMO News
Aragen Bioscience and Getinge’s Successful Validation of Single-Use Production Reactors
Aragen Bioscience and Getinge, a Swedish life sciences service provider, have announced a successful validation of Getinge’s Single-Use Production Reactors (SUPR) for large-scale recombinant antibody production. This collaboration combines Aragen’s biopharmaceutical manufacturing expertise and Getinge’s single-use technology, aiming to enable seamless
7 June 2024